Evidence map›Paper›PMID 31428378›Full record

ArticleClinical case reports2019

The first report of

Masoud Keikha, Tahereh Soori, Davood Azadi, Morteza Karami-Zarandi, Maryam Daneshpazhooh, Hosssein Ali Rahdar

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The first report ofClinical case reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masoud KeikhaAntimicrobial Resistance Research Center Mashhad University of Medical Sciences Mashhad Iran.
Tahereh SooriDepartment of Infection Disease, School of Medicine Tehran University of Medical Sciences Tehran Iran.
Davood AzadiDepartment of Laboratory Sciences Khomein University of Medical Sciences Khomein Iran.
Morteza Karami-ZarandiDepartment of Medical Microbiology, School of Medicine Tehran University of Medical Sciences Tehran Iran.
Maryam DaneshpazhoohDepartment of Dermatology, Autoimmune Bullous Diseases Research Center Tehran University of Medical Sciences Tehran Iran.
Hosssein Ali RahdarDepartment of Medical Microbiology, School of Medicine Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0003-1583-9936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is one of the neglected chronic inflammatory disorders which has not efficient treatment. These patients were susceptible to various infectious diseases because of their changes in immuneresponse. Also, HS pathogenesis remains unclear and its report can create novel insight into mechanism and pathogenesis of this infection. Moreover, given that different susceptibility patterns of

Indexed as

hidradenitis suppurativainfectionPseudomonas oryzihabitans

Identifiers

PMID31428378
PMCPMC6693057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.